Chimpanzees drum with regular rhythm when they beat on tree trunks, a form of ancient communication
Chimpanzees and humans last shared a common ancestor around 6 million years ago. Scientists suspect this ancient ancestor must have been a drummer — using beats to communicate.
'Our ability to produce rhythm — and to use it in our social worlds — that seems to be something that predates humans being human,' said study co-author Cat Hobaiter, a University of St Andrews primatologist.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Cell Dissociation Market Size Projected to Attain USD 1,451.89 Million by 2034
The global cell dissociation market is valued at USD 461.55 million in 2025 and is projected to reach approximately USD 1,451.89 million by 2034, expanding at a CAGR of 13.58% during the forecast period. Ottawa, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global cell dissociation market size valued at USD 406.36 million in 2024, is projected to reach approximately USD 1,451.89 million by 2034, growing at a CAGR of 13.58%, according to a study by , a sister company of Precedence Research. Widespread application of cell dissociation in diagnostics, study of diseases, isolation of various cell products, etc, due to which the cell dissociation market is progressing. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America led the market share by 38% in 2024. Asia Pacific is expected to be the fastest-growing region in the coming years. By product, the enzymatic dissociation segment dominated the cell dissociation market in 2024. By product, the non-enzymatic dissociation segment is expected to grow at the fastest CAGR during 2025-2034. By type, the tissue dissociation segment held a major share of the market in 2024. By type, the cell detachment segment is expected to witness rapid expansion in the studied years. By end-user, the pharmaceutical & biotechnology companies segment led the cell dissociation market in 2024 and is expected to grow rapidly during the forecast period. Market Overview & Potential The process in which individual cells are separated from a tissue or cell culture, usually for research or therapeutic applications, is known as cell dissociation. Primarily, they are employed in stem cell research, cancer research, tissue engineering, and drug discovery. Currently, the cell dissociation market is experiencing progression in enzymatic and mechanical methods, as well as the involvement of innovative technologies, such as portable electrical devices. Basic use of cell dissociation in the development of regenerative medicine encompasses cell isolation, manipulation, and then reintroduction into the body. Market Scope Metric Details Market Size in 2024 USD 406.36 Million Projected Market Size in 2034 USD 1451.89 Million CAGR (2025 - 2034) 13.58 % Leading Region North America Market Segmentation By Product, By Type, By End-use, By Region Top Key Players Merck KGaA, Thermo Fisher Scientific, Danaher Corp., STEMCELL Technologies, Sartorius AG, BD, Miltenyi Biotec, PAN-Biotech, HiMedia Laboratories, F. Hoffmann-La Roche Ltd., S2 Genomics, Inc. What are the Key Growth Drivers Involved in The Expansion of The Market? Around the world, the developing utilization of cell-based assays in drug discovery and development, as well as in customized medicine, is leading to an increased demand for robust cell dissociation products. The cell dissociation market is further driven by tremendous applications in the escalating demand for cell-based therapies, especially stem cell and gene therapies. Besides this, advancing research techniques, like automation and integration with omics technologies, are supporting process efficiency and further expansion of the market. You can place an order or ask any questions, please feel free to contact us at sales@ What Are the Trends Associated with the Cell Dissociation Market? In 2025, the growing emergence of numerous biotechnology and pharmaceutical industries in research and development is impacting the overall market growth. In July 2025, SPT Labtech, a global company in innovative laboratory automation, collaborated with Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory, to advance automated cell-based assay workflows. In April 2025, EditCo Bio, Inc. and Promega Corporation partnered to empower the era of biologically related cell-based research, such as HiBiT, HaloTag®, and NanoLuc® technologies. In November 2024, Singleron Biotechnologies, a player in single-cell analysis solutions, made a partnership with TOMY Digital Biology Co., Ltd to enable access to Singleron's comprehensive range of single-cell analysis products and services. What Is the Major Limitation in the Market? The cell dissociation market is facing certain challenges, mainly the maintenance of high cell viability and purity after the dissociation process in the production of biopharmaceuticals and cell-based therapies. Besides this, expensive specialized enzymes, automated systems, and other reagents are creating a hindrance to developing cell dissociation technologies. Regional Analysis Become a valued research partner with us - Why did North America Dominate the Cell Dissociation Market in 2024? The market is propelled by immense investments in life sciences research in this region, impacting market development, primarily in the US. Moreover, this region possesses advanced biotechnology and a pharmaceutical industry, and a strong healthcare infrastructure. Along with this, North America's emphasis on the development of precision medicine, 3D cell culture models, and advanced therapies like gene editing is expanding demand for more sophisticated and effective cell dissociation solutions. For instance, In March 2025, RoslinCT and Ayrmid Pharma made a strategic partnership for the production of Omisirge®, a treatment for hematologic malignancies commercialized in the United States by Gamida Cell, a subsidiary of Ayrmid Pharma. In October 2024, FibroBiologics Inc., a clinical-stage biotechnology company, and Charles River Laboratories, a leading drug discovery, development, testing, and manufacturing solutions provider, signed an agreement to develop and manufacture FibroBiologics' therapeutic master cell bank, working cell bank, and fibroblast-based spheroids product, CYWC628. What Made the Asia Pacific Significantly Grow in the Market in 2024? During 2025-2034, the Asia Pacific will expand at the fastest CAGR in the cell dissociation market. Combined factors are impacting the overall market expansion in the ASAP countries, such as China. Japan, India, and South Korea. An expanding healthcare system, with increased focus on R&D, especially in regenerative medicine and stem cell research, is widely involved in the market expansion. Apart from this, ongoing government initiatives to boost the biotechnology domain and accelerate the pipeline in clinical research activities are also propelling the adoption of innovative technologies. For this market, In August 2025, CytoNiche Biotech, a leader in 3D cell production technology, inaugurated its 3D FloTrix™ Experience Hub in Singapore. In July 2025, NKGen Biotech, Inc., a clinical-stage biotechnology company, and Japan-based HekaBio K.K., partnered to expand the regulatory, manufacturing, and commercial development of NKGen's autologous NK cell therapy, troculeucel, in Japan following HekaBio's recently announced investment in common equity of NKGen. Get the latest insights on life science industry segmentation with our Annual Membership: Segmental Insights By product analysis How did the Enzymatic Dissociation Segment Lead the Market in 2024? In 2024, the enzymatic dissociation segment registered dominance in the cell dissociation market. This type of product can give higher cell yield with broader effectiveness at extracting cells from dense or complex tissues as compared to other mechanical methods. Moreover, this approach offers its flexibility in different downstream applications, like flow cytometry, cell sorting, and in vitro assays. Alongside its wide-range utilization in the development of numerous cell-based therapies and its ability to minimize the amount of fibrous connective tissue present in the cell suspension, it boosts further cell viability and downstream analysis in the market. However, the non-enzymatic dissociation segment is predicted to experience rapid growth in the studied years. This product type has several advantages, like it can preserve cell surface proteins, which is vital for downstream assays. Furthermore, non-enzymatic dissociation is favourable for sensitive cells. Also, they are obtained without animal-derived components, making them adaptable for various cell-based therapies is driving overall segment and market expansion. Whereas, non-enzymatic dissociation is greatly employed in isolating and expanding MSCs while protecting their key functional properties. By type analysis Which Type Held the Largest Share of the Cell Dissociation Market in 2024? The tissue dissociation segment dominated the market with a major share in 2024. The segment is driven by rising research in oncology, chronic conditions, and breakthroughs in cell-based therapies. This type mainly contributes to the separation of cells from a tissue sample to create a single-cell suspension, which is further necessary for isolating cells for therapeutic use, research, and diagnostics. Moreover, the cell detachment segment is estimated to grow fastest during 2025-2034. The significance of cell detachments in cell culture, particularly in culturing adherent cells, is increasingly applied in many research and therapeutic applications. Along with this, a rise in demand for monoclonal antibodies in biopharmaceutical and pharmaceutical industries is immensely dependent on cell culture and, consequently, cell detachment techniques. Eventually, they encompass mechanical detachment (scraping or shaking) and physical methods, such as thermal, light, or magnetic manipulation, which can be selected based on the cell type, culture conditions, and downstream applications. By end-user analysis What Made the Pharmaceutical & Biotechnology Companies Segment Dominate in the Market in 2024? The pharmaceutical & biotechnology companies segment was dominant in the cell dissociation market in 2024 and will expand at the fastest CAGR. Widespread use of cell dissociation is seen in these companies, particularly in vaccine development, production of diverse biopharmaceutical products, and cancer research. Additionally, the segment is fueled by the adoption of cell dissociation in drug discovery and development, allowing the generation of single-cell suspensions, which are essential for high-throughput screening of possible drug candidates. The utilization of the single-cell RNA sequencing (scRNA-seq) technique relies on cell dissociation for the analysis of gene expression profiles in individual cells, demonstrating significant insights into drug responses and cellular heterogeneity. Recent Developments in the Cell Dissociation Market In July 2025, AscellaHealth, a leading partner delivering customizable solutions to support the specialty pharmaceutical industry, partnered with Abeona Therapeutics Inc. for pre- and post-launch commercialization of ZEVASKYN™, an FDA-approved cell-based gene therapy. In April 2025, Singleron Biotechnologies launched PythoN i, an advanced tissue having in nuclei extraction and tissue homogenization functions to its tissue processing system. In March 2025, Sphere Bio, a major provider of innovative picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, introduced the Cyto-Cellect® Human IgG Kappa and Viability Assay Kit, the first multiplexed assay developed specifically for the Company's new Cyto-Mine® Chroma platform. In April 2024, Kuraray Co., Ltd. developed PVA (Polyvinyl Alcohol) hydrogel microcarriers for cell cultures used in regenerative medicine. Browse More Insights of Towards Healthcare: The global single-cell sequencing market was valued at US$ 1.63 billion in 2024 and is anticipated to rise to US$ 1.88 billion by 2025. By 2034, the market is projected to exceed US$ 6.65 billion, advancing at a CAGR of 15.05%. The global cellular immunotherapy market reached US$ 11.33 billion in 2024 and is expected to grow to US$ 13.87 billion in 2025, before surging to nearly US$ 85.78 billion by 2034, expanding at a robust CAGR of 22.45% during the forecast period. The global cell and gene therapy clinical trials market was valued at US$ 10.8 billion in 2024, grew to US$ 12.47 billion in 2025, and is projected to achieve US$ 45.31 billion by 2034, registering a CAGR of 15.43% from 2025 to 2034. The global cell-based assays market stood at US$ 17.29 billion in 2024 and is forecast to increase to US$ 18.82 billion in 2025. By 2034, it is anticipated to surpass US$ 39.92 billion, advancing at a CAGR of 8.84%. The global biopharmaceutical contract manufacturing market was calculated at US$ 40.14 billion in 2024, expanded to US$ 44.61 billion in 2025, and is projected to reach approximately US$ 115.65 billion by 2034, growing at a CAGR of 11.14% between 2025 and 2034. The global cell and gene solutions market is on a strong growth trajectory, with revenue expected to scale significantly over the forecast years from 2025 to 2034, potentially reaching into the hundreds of millions. The global cell-based immunotherapies market was valued at US$ 4.59 billion in 2024, is set to grow to US$ 5.28 billion in 2025, and is projected to generate US$ 18.62 billion by 2034, expanding at a CAGR of 15.02% throughout the forecast period. The global cell banking outsourcing market reached US$ 14.37 billion in 2024, expanded to US$ 16.72 billion in 2025, and is forecast to hit US$ 63.49 billion by 2034, growing at a strong CAGR of 16.37%. The global stem cell banking market was valued at US$ 7.85 billion in 2024, grew to US$ 9.12 billion in 2025, and is projected to climb to US$ 35.12 billion by 2034, advancing at a CAGR of 16.14% between 2025 and 2034. The global host cell protein testing market stood at US$ 2.37 billion in 2024, increased to US$ 2.56 billion in 2025, and is projected to cross US$ 5.19 billion by 2034, expanding at a CAGR of 8.17%. The global stem cell assay market was valued at US$ 2.68 billion in 2024, grew to US$ 3.15 billion in 2025, and is expected to achieve US$ 13.5 billion by 2034, rising at a significant CAGR of 17.55%. The global live cell imaging market reached US$ 2.92 billion in 2024, expanded to US$ 3.16 billion in 2025, and is anticipated to generate US$ 6.49 billion by 2034, progressing at a CAGR of 8.34%. The global immortalized cell line market was valued at US$ 4.55 billion in 2024, increased to US$ 4.85 billion in 2025, and is projected to attain US$ 8.68 billion by 2034, advancing at a CAGR of 6.71%. The global cell viability assays market stood at US$ 1.89 billion in 2024, grew to US$ 2.05 billion in 2025, and is projected to reach US$ 4.24 billion by 2034, expanding at a CAGR of 8.54%. The global stem cell reconstructive market was valued at US$ 1.56 billion in 2024, is forecast to grow to US$ 1.88 billion in 2025, and is expected to achieve US$ 10.32 billion by 2034, advancing at an impressive CAGR of 20.81%. Cell Dissociation Market Key Players Merck KGaA Thermo Fisher Scientific Danaher Corp. STEMCELL Technologies Sartorius AG BD Miltenyi Biotec PAN-Biotech HiMedia Laboratories F. Hoffmann-La Roche Ltd. S2 Genomics, Inc. Segments Covered in The Report By Product Enzymatic Dissociation Trypsin Collagenase Elastase Papain Hyaluronidase DNase Others Non-enzymatic dissociation Instruments & Accessories By Type Tissue Dissociation Cell Detachment By End-use Pharmaceutical & Biotechnology Companies Research & Academic Institutes By Region North America U.S. Canada Mexico Europe Germany UK Spain Italy France Denmark Norway Sweden Asia Pacific Japan China India Australia Thailand South Korea Latin America Brazil Argentina MEA South Africa Saudi Arabia UAE Kuwait Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway. Access the Dashboard: Immediate Delivery Available | Buy This Premium Research @ About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. You can place an order or ask any questions, please feel free to contact us at sales@ Europe Region: +44 778 256 0738 North America Region: +1 8044 4193 44 Web: Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | PinterestError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
How climate change is making Europe's fish move to new waters
Climate change is reshaping fish habitats. Some fish are winners, others are losing out. Fish already face plenty of pressure from overfishing and pollution. Climate change is adding more: warmer waters and shifting food supplies cause what's known as a predator-prey mismatch. This means prey and predator are not in the same place at the same time, which not only affects our diets but also fishing industries and ocean health more widely. As the ocean heats up, fish try to stay in the conditions they're best suited to. Some species will move, but others can't relocate so easily – for example, if they need to live in a certain habitat at a particular life-stage, such as in kelp that offers shelter for breeding. So, depending on the species and location, climate change could create new fishing opportunities for some countries, and big losses for others. Fisheries managers typically group fish into 'stocks'. These are populations of the same species in a defined region, often based on national borders. But those human-made boundaries don't matter to fish. As they shift in response to climate change, managing their populations will become more complex and will need to be flexible and responsive. By 2050, waters around the UK are expected to warm by about 1°C if we follow a 'moderate' emissions path. If emissions continue to rise unchecked, the increase could reach 2-3°C by the end of the century. At the same time, the food that fish eat (such as tiny plankton) could drop by as much as 30%. My team and I used advanced computer modelling to predict how 17 key commercial species such as mackerel, cod, plaice, tuna and sardines might respond to two future climate scenarios. Our results show a patchwork of winners and losers. Take sardines and mackerel. These species live in the upper ocean and are sensitive to temperature. Both are expected to shift northward. This shift would be around 20 miles in the North Sea and up to 80 miles in the north-east Atlantic by 2100 under a moderate emissions scenario. While sardines may thrive, with a 10% boost in Atlantic abundance, our model suggests mackerel could decline by 10% in the Atlantic and 20% in the North Sea. Consequently, the type and quantity of fish available will change. Warm-water species like bluefin tuna may benefit within UK waters. Tuna is projected to shift only slightly (by approximately 4 miles) under the same scenario, but their abundance could rise by 10%, potentially bringing more of them into UK waters. That's good news for fishers already targeting this high-value catch, or those looking to change their main target species. But bottom-dwelling species like cod and saithe (pollock) face a tougher future. These fish prefer colder, deeper waters and have fewer options to escape warming seas due to depth limitations. In the North Sea, they're projected to shift southward by around 9 miles because that's where the remaining cool, deep water is. But this won't be enough to avoid a significant decline in their numbers: their populations are expected to drop by 10-15% under a moderate scenario by 2050. Do the seasons feel increasingly weird to you? You're not alone. Climate change is distorting nature's calendar, causing plants to flower early and animals to emerge at the wrong time. This article is part of a series, Wild Seasons, on how the seasons are changing and what they may eventually look like. Changing tides And if climate change accelerates, the declines become far more severe. By the end of the century, North Sea cod and saithe could fall by 30-40%, according to our model. Mackerel abundance could drop by 25% in the Atlantic, while sardines might see only a modest 5% increase, despite moving 155 miles northward. Bluefin tuna could see a 40% rise in numbers, shifting 27 miles further north. We've estimated how species will shift their locations – but computer models can't account for every interaction between marine species. For example, predator-prey relationships can be crucial in shaping an ecosystem. Bluefin tuna is a predatory species which hunts shoals of herring, mackerel and other fish. Other predators including dolphins, seals and seabirds will all be influenced differently by climate change, with varying responses in terms of eating their favourite fish snacks. Our projections also don't account for continued fishing pressure – for example, 24% of north-east Atlantic fisheries are not sustainable. Further overfishing will compound the strain on fish populations. To keep stocks healthy, fishery managers need to start planning for these changes now by factoring climate into their stock assessments. Industry regulators will also need to reconsider who gets to fish where as species move. Fish don't carry passports. Their shifting habitats will challenge longstanding fishing agreements and quotas. Nations that once relied on particular species might lose access. Others may find new, unexpected opportunities. With smart management and serious action on climate, seafood can thrive in the future. Doing nothing now isn't an option — unless we want familiar favourites like cod to vanish from our plates. Get a weekly roundup in your inbox instead. Every Wednesday, The Conversation's environment editor writes Imagine, a short email that goes a little deeper into just one climate issue. Join the 45,000+ readers who've subscribed so far. This article is republished from The Conversation under a Creative Commons license. Read the original article. Sevrine Sailley receives funding from UKRI and Horizon Europe.
Gizmodo
4 hours ago
- Gizmodo
White Noise Makes Beer Brew Faster, Scientists Claim
Music can make people do things faster, with running, dancing, and doing chores being good examples. It seems, however, that we're not alone in picking up the pace at the sound of a good tune. Researchers have discovered that playing a sound commonly known as white noise can shorten fermentation—arguably the most important step in brewing beer—by 21 to 31 hours, without markedly changing the flavor. This could help breweries increase beer production without diminishing quality. Sound consists of two parts: pressure changes (with areas of compression and rarefaction) and particle motion, where particles in the medium vibrate and pass that movement to nearby particles. 'This study investigates the effect that the particle motion component of audible sound has on beer fermentations using linear actuators (LAT) that predominantly deliver the particle motion component of sound rather than the pressure component,' the researchers wrote in a paper published in May in the journal Food Research International. In other words, the scientists wanted to find out if vibrations, rather than loud sound pressure, might speed up the fermentation process. Fermentation is when yeast—strains of single-celled fungi species—converts sugars into alcohol and carbon dioxide. The process can take days to weeks, but when the researchers used specialized devices, the LATs, to transmit the white noise into the beer, the fermentation happened faster. 'The application of sound stimulation increased the yeast growth by maintaining a higher concentration of yeast cells in suspension,' Parise Adadi, lead author of the study and a researcher in food sciences at the University of Otago – Ōtākou Whakaihu Waka, said in a university statement. 'The sound energy stimulated cellular processes and metabolic pathways, enhancing yeast growth and activity. This led to faster consumption of wort sugars and subsequent production of alcohol; but importantly did not significantly alter the flavour composition of the final beer.' Adadi and his colleagues concluded this after comparing two batches of beer: one that experienced the sound simulation and one that did not. The beer that was treated with sound fermented faster. For the experiments, the scientists used white noise between 800 and 2,000 hertz, delivered at intensities close to 140 decibels. Faster fermentation boosts production efficiency, allowing brewmasters to make more beer without sacrificing quality. And since it has little effect on volatile compounds, the flavor and aroma stay consistent, Adadi explained. 'Furthermore, if audible sound stimulation proves scalable, it could revolutionise fermentation technology, sparking innovations across other fermented products such as wine and spirits,' he added. Adadi and his team's work could also have implications outside of the alcohol industry. Think how fast you could make yogurt, kombucha, sauerkraut, and kimchi!
